GR77916B - - Google Patents

Info

Publication number
GR77916B
GR77916B GR70653A GR830170653A GR77916B GR 77916 B GR77916 B GR 77916B GR 70653 A GR70653 A GR 70653A GR 830170653 A GR830170653 A GR 830170653A GR 77916 B GR77916 B GR 77916B
Authority
GR
Greece
Application number
GR70653A
Other languages
Greek (el)
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US06/354,851 external-priority patent/US4406899A/en
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GR77916B publication Critical patent/GR77916B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14—Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR70653A 1982-03-04 1983-03-02 GR77916B (enExample)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/354,851 US4406899A (en) 1982-03-04 1982-03-04 Cephalosporins
US35753482A 1982-03-12 1982-03-12

Publications (1)

Publication Number Publication Date
GR77916B true GR77916B (enExample) 1984-09-25

Family

ID=26998584

Family Applications (1)

Application Number Title Priority Date Filing Date
GR70653A GR77916B (enExample) 1982-03-04 1983-03-02

Country Status (29)

Country Link
KR (1) KR870001986B1 (enExample)
AT (2) AT382155B (enExample)
AU (1) AU562776B2 (enExample)
BE (1) BE896086A (enExample)
CA (1) CA1213882A (enExample)
CH (1) CH654313A5 (enExample)
CS (1) CS249512B2 (enExample)
DD (1) DD210280A5 (enExample)
DE (1) DE3307550A1 (enExample)
DK (1) DK156900C (enExample)
EG (1) EG15934A (enExample)
ES (2) ES520224A0 (enExample)
FI (1) FI74973C (enExample)
FR (1) FR2522659B1 (enExample)
GB (1) GB2116180B (enExample)
GR (1) GR77916B (enExample)
HU (1) HU193158B (enExample)
IE (1) IE56647B1 (enExample)
IL (1) IL68011A0 (enExample)
IT (1) IT1170307B (enExample)
LU (1) LU84674A1 (enExample)
MY (1) MY8700943A (enExample)
NL (2) NL193284C (enExample)
NZ (1) NZ203312A (enExample)
PH (1) PH18002A (enExample)
PT (1) PT76330B (enExample)
SE (1) SE453091B (enExample)
SU (1) SU1250173A3 (enExample)
YU (2) YU43822B (enExample)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3409431A1 (de) * 1983-10-08 1985-04-18 Hoechst Ag, 6230 Frankfurt Cephalosporinderivate und verfahren zu ihrer herstellung
DE3404906A1 (de) * 1984-02-11 1985-08-14 Bayer Ag, 5090 Leverkusen 1-oxadethiacephalosporinderivate sowie verfahren zu ihrer herstellung
DE3419013A1 (de) * 1984-05-22 1985-11-28 Bayer Ag, 5090 Leverkusen Neue cephalosporine und verfahren zu ihrer herstellung
GB8424692D0 (en) * 1984-10-01 1984-11-07 Glaxo Group Ltd Chemical compounds
US4698336A (en) * 1985-01-30 1987-10-06 Eisai Co., Ltd. 3-(pyrrolidinio)methyl-3-cephem derivatives
CA1284994C (en) * 1985-08-05 1991-06-18 Murray Arthur Kaplan Cephalosporin salts and injectable compositions
US4910301A (en) * 1985-08-05 1990-03-20 Bristol-Myers Company Cefepime cephalosporin salts
US4808617A (en) * 1985-12-18 1989-02-28 Bristol-Myers Company Lyophilized or precipitated cephalosporin zwitterion and salt combination
EP0237735B1 (en) * 1986-03-17 1994-03-30 Fujisawa Pharmaceutical Co., Ltd. 3,7-Disubstituted-3-cephem compounds and process for production of the same
CA2011116C (en) * 1989-03-06 1999-11-16 Murray A. Kaplan Lyophilized bmy-28142 dihydrochloride for parenteral use
DK0503453T3 (da) 1991-03-08 2001-07-16 Biochemie Gmbh Fremgangsmåde til fremstilling af cephalosporiner og mellemprodukter i denne fremgangsmåde
MY108872A (en) * 1991-09-10 1996-11-30 Bristol Myers Squibb Co Preparation of a cephalosporin antibiotic using the syn-isomer of a thiazolyl intermediate.
YU81692A (sh) * 1991-09-10 1995-03-27 Bristol-Myers Co. Postupak za proizvodnju cefalosporinskog antibiotika
US5523400A (en) * 1993-04-16 1996-06-04 Hoffmann-La Roche Inc. Cephalosporin antibiotics
ES2298850T3 (es) * 2003-12-23 2008-05-16 Sandoz Gmbh Proceso para la produccion de intermedios para utilizar en la sintesis de la cefalosporina.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2760484C2 (enExample) * 1976-04-14 1992-12-03 Takeda Chemical Industries, Ltd., Osaka, Jp
GB1591439A (en) * 1976-10-01 1981-06-24 Glaxo Operations Ltd 7-syn (oxyimino -acylamido) cephalosporins
AR229883A1 (es) * 1978-05-26 1983-12-30 Glaxo Group Ltd Procedimiento para la preparacion de antibiotico(6r,7r)-7-((z)-2-(2-aminotiazol-4-il)-2-(2-carboxiprop-2-oxiimino)-acetamido)-3-(1-piridinometil)-cef-3-em-4-carboxilato
DE2943437A1 (de) * 1978-10-27 1980-05-08 Glaxo Group Ltd Cephalosporinverbindungen
US4443444A (en) * 1980-08-11 1984-04-17 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds

Also Published As

Publication number Publication date
SE8301178L (sv) 1983-09-05
PT76330B (en) 1986-02-04
NZ203312A (en) 1985-12-13
DD210280A5 (de) 1984-06-06
YU52383A (en) 1986-02-28
HU193158B (en) 1987-08-28
SE453091B (sv) 1988-01-11
EG15934A (en) 1987-10-30
DK156900C (da) 1990-03-12
NL193284C (nl) 1999-05-06
IE830455L (en) 1983-09-04
FI74973B (fi) 1987-12-31
PT76330A (en) 1983-04-01
FR2522659A1 (fr) 1983-09-09
IT1170307B (it) 1987-06-03
SE8301178D0 (sv) 1983-03-03
PH18002A (en) 1985-02-28
ATA76183A (de) 1986-06-15
AT382155B (de) 1987-01-26
IL68011A0 (en) 1983-06-15
DE3307550A1 (de) 1983-09-15
DK156900B (da) 1989-10-16
ES526397A0 (es) 1985-09-16
ES8507557A1 (es) 1985-09-16
DE3307550C2 (enExample) 1988-11-24
DK86283D0 (da) 1983-02-24
FI74973C (fi) 1988-04-11
SU1250173A3 (ru) 1986-08-07
LU84674A1 (fr) 1983-11-17
AU1130483A (en) 1983-09-08
CH654313A5 (de) 1986-02-14
NL990039I2 (nl) 2000-04-03
AT384612B (de) 1987-12-10
MY8700943A (en) 1987-12-31
NL8300755A (nl) 1983-10-03
BE896086A (fr) 1983-09-05
AU562776B2 (en) 1987-06-18
IT8347826A0 (it) 1983-03-01
NL193284B (nl) 1999-01-04
KR870001986B1 (ko) 1987-10-24
DK86283A (da) 1983-09-05
YU43822B (en) 1989-12-31
YU149685A (en) 1986-02-28
KR840004118A (ko) 1984-10-06
ATA228285A (de) 1987-05-15
CA1213882A (en) 1986-11-12
FI830689A0 (fi) 1983-03-01
IE56647B1 (en) 1991-10-23
NL990039I1 (nl) 2000-01-03
ES8403919A1 (es) 1984-04-01
FI830689L (fi) 1983-09-05
CS249512B2 (en) 1987-03-12
GB8305940D0 (en) 1983-04-07
FR2522659B1 (fr) 1986-10-24
YU44777B (en) 1991-02-28
GB2116180A (en) 1983-09-21
GB2116180B (en) 1985-09-18
ES520224A0 (es) 1984-04-01

Similar Documents

Publication Publication Date Title
DE3347807A1 (enExample)
DK8504588A (enExample)
FR2521386B1 (enExample)
DE3348031A1 (enExample)
FR2519531B3 (enExample)
DE3249743A1 (enExample)
FR2519336B1 (enExample)
CH655653B (enExample)
CH655668B (enExample)
CH655523B (enExample)
CH655524B (enExample)
CH655464B (enExample)
CH655584B (enExample)
CH655492B (enExample)
CH655407B (enExample)
FR2520402B1 (enExample)
CH655636B (enExample)
FR2519252B3 (enExample)
CH652562GA3 (enExample)
FR2528496B3 (enExample)
AU527338B1 (enExample)
AU525597B1 (enExample)
FR2519507B1 (enExample)
FR2524870B1 (enExample)
JPS613850B2 (enExample)